Your browser doesn't support JavaScript. Please upgrade to a modern browser or enable JavaScript in your existing browser.
Skip Navigation U.S. Department of Health and Human Services www.hhs.gov
Agency for Healthcare Research Quality www.ahrq.gov
AHRQ Home | Questions? | Contact Us | Site Map | What's New | Browse | Información en español | E-mail UpdatesE-mail Updates
www.ahrq.gov

Figure 3. Screening and Treating Adults for Lipid Disorders: Methods

Screening for lipid disorders: analytic framework and key questions. Numbers refer to key questions (KQ) as follows: KQ 1. What is the accuracy of screening for detecting persons at increased risk of CHD because of abnormal lipids? KQ 2. What is the effectiveness of diet therapy or exercise or drug therapy in reducing the incidence of mortality from CHD in asymptomatic people with abnormal lipids? KQ3. What are the adverse effects of screening? KQ4. What are the adverse effects of diet or drug treatment?

Return to Document

 
AHRQ Advancing Excellence in Health Care